FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Brigitte Bressac De-Paillerets

Research Profile

Physiology

Disorders

Concepts & Ideas

Genes & Molecular Sequences

Genes, p16

Chemicals & Drugs

Procedures

Geographic Areas

France

Co-author Network

Publications

TOP 3
Eve Maubec; Hamida Mohamdi; Jean-Luc Perrot; Luc Thomas; Pierre Vabres; Lynda Vincent-Fetita; Hélène Zattara; Marie-Françoise Avril; Christophe Blondel; Françoise Boitier; Brigitte Bressac De-Paillerets; Valérie Chaudru; Eve Corda; Béatrice Crickx; Stéphane Dalle; Sébastien Forget; Florent Grange; Pascal Joly; Marie-Thérèse Leccia; Dominique Stoppa Lyonnet; Sandrine Mansard; Patricia Margaritte-Jeannin; Ludovic Martin; Florence Demenais
Familial melanoma: clinical factors associated with germline CDKN2A mutations according to the number of patients affected by melanoma in a family.
Claude Houdayer; Sophie Krieger; Cédrick Lefol; Mélanie Léone; Rosette Lidereau; Sylvie Mazoyer; Danielle Muller; Audrey Remenieras; Françoise Révillion; Etienne Rouleau; Nicolas Sevenet; Olga M Sinilnikova; Hagay Sobol; Joanna Sokolowska; Florent Soubrier; Michel BARROIS; Françoise Bonnet; Violaine Bourdon; Brigitte Bressac De-Paillerets; Myriam Bronner; Monique Buisson; Virginie Caux-Moncoutier; Florence Coulet; Pascaline Gaildrat; Agnès Hardouin; Mario Tosi; Jean-Philippe Vert; Dominique Stoppa-Lyonnet
Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants.
Laurence Brugières; Véronique Byrde; Olivier Caron; Olivier Delattre; Christelle Dufour; Sébastien Forget; Gaëlle Pierron; Stephanie PUGET; Audrey Remenieras; Pascale Varlet; Johny Bombled; Brigitte Bressac De-Paillerets; Jacques Grill
High frequency of germline SUFU mutations in children with desmoplastic/nodular medulloblastoma younger than 3 years of age.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Brigitte Bressac De-Paillerets (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Eve Maubec; Hamida Mohamdi; Jean-Luc Perrot; Luc Thomas; Pierre Vabres; Lynda Vincent-Fetita; Hélène Zattara; Marie-Françoise Avril; Christophe Blondel; Françoise Boitier; Brigitte Bressac De-Paillerets; Valérie Chaudru; Eve Corda; Béatrice Crickx; Stéphane Dalle; Sébastien Forget; Florent Grange; Pascal Joly; Marie-Thérèse Leccia; Dominique Stoppa Lyonnet; Sandrine Mansard; Patricia Margaritte-Jeannin; Ludovic Martin; Florence Demenais
Familial melanoma: clinical factors associated with germline CDKN2A mutations according to the number of patients affected by melanoma in a family.
Journal of the American Academy of Dermatology 2012;67(6):1257-64.
2012: Claude Houdayer; Sophie Krieger; Cédrick Lefol; Mélanie Léone; Rosette Lidereau; Sylvie Mazoyer; Danielle Muller; Audrey Remenieras; Françoise Révillion; Etienne Rouleau; Nicolas Sevenet; Olga M Sinilnikova; Hagay Sobol; Joanna Sokolowska; Florent Soubrier; Michel BARROIS; Françoise Bonnet; Violaine Bourdon; Brigitte Bressac De-Paillerets; Myriam Bronner; Monique Buisson; Virginie Caux-Moncoutier; Florence Coulet; Pascaline Gaildrat; Agnès Hardouin; Mario Tosi; Jean-Philippe Vert; Dominique Stoppa-Lyonnet
Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants.
Human mutation 2012;33(8):1228-38.
2012: Laurence Brugières; Véronique Byrde; Olivier Caron; Olivier Delattre; Christelle Dufour; Sébastien Forget; Gaëlle Pierron; Stephanie PUGET; Audrey Remenieras; Pascale Varlet; Johny Bombled; Brigitte Bressac De-Paillerets; Jacques Grill
High frequency of germline SUFU mutations in children with desmoplastic/nodular medulloblastoma younger than 3 years of age.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(17):2087-93.
2012: Corine Bertolotto; Fabienne Lesueur; Brigitte Bressac De-Paillerets
[MITF: a genetic key to melanoma and renal cell carcinoma?].
Médecine sciences : M/S 2012;28(3):258-61.
2011: Mickael Ohanna; Jean-François Peyron; Caroline Robert; Stéphane Rocchi; Joséphine Zangari; Robert Ballotti; Karine Bille; Caroline Bonet; Brigitte Bressac De-Paillerets; Sandy Giuliano; Paul Hofman; Véronique Hofman; Véronique Imbert; Jean-Philippe Lacour; Corine Bertolotto
Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS).
Genes & development 2011;25(12):1245-61.
2010: B Buecher; Marion Gauthier-Villars; Laurence Desjardins; Livia Lumbroso-Le Rouic; Christine Levy; A De Pauw; J Bombled; C Tirapo; C Houdayer; Brigitte Bressac De-Paillerets; Dominique Stoppa-Lyonnet
Contribution of CDKN2A/P16 ( INK4A ), P14 (ARF), CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma.
Familial cancer 2010;9(4):663-7.
2010: Marina Muzza; Daniela Cordella; Johny Bombled; Brigitte Bressac De-Paillerets; Fabiana Guizzardi; Zelia Francis; Paolo Beck-Peccoz; Martin Schlumberger; Luca Persani; Laura Fugazzola
Four novel RET germline variants in exons 8 and 11 display an oncogenic potential in vitro.
European journal of endocrinology / European Federation of Endocrine Societies 2010;162(4):771-7.
2009: Julie Tinat; Gaelle Bougeard; Stephanie Baert-Desurmont; Stéphanie Vasseur; Cosette Martin; Emilie Bouvignies; Olivier Caron; Brigitte Bressac De-Paillerets; Pascaline Berthet; Catherine Dugast; Catherine Bonaïti-Pellié; Dominique Stoppa-Lyonnet; Thierry Frébourg
2009 version of the Chompret criteria for Li Fraumeni syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(26):e108-9; author reply e110.
2008: Emma R Woodward; Christopher Ricketts; Pip Killick; Sophie Gad; Mark Morris; Fred Kavalier; Shirley V Hodgson; Sophie Giraud; Brigitte Bressac De-Paillerets; Cyril Chapman; Bernard Escudier; Farida Latif; Stéphane Richard; Eamonn R Maher
Familial non-VHL clear cell (conventional) renal cell carcinoma: clinical features, segregation analysis, and mutation analysis of FLCN.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(18):5925-30.
2008: Caroline Kannengiesser; Alain Spatz; Stefan Michiels; Alain Eychène; Philippe Dessen; Vladimir Lazar; Véronique Winnepenninckx; Fabienne LESUEUR; Sabine Druillennec; Caroline Robert; Joost J van den Oord; Alain Sarasin; Brigitte Bressac De-Paillerets
Gene expression signature associated with BRAF mutations in human primary cutaneous melanomas.
Molecular oncology 2008;1(4):425-30.
2007: Caroline Kannengiesser; Stéphane Dalle; Marie-Thérèse Leccia; Marie-Françoise Avril; Valérie Bonadona; Agnès Chompret; Christine Lasset; Dominique Leroux; Luc Thomas; Fabienne LESUEUR; Gilbert Lenoir; Alain Sarasin; Brigitte Bressac De-Paillerets
New founder germline mutations of CDKN2A in melanoma-prone families and multiple primary melanoma development in a patient receiving levodopa treatment.
Genes, chromosomes & cancer 2007;46(8):751-60.
2007: Sophie Gad; S H Lefèvre; S K Khoo; Sophie Giraud; Annick Vieillefond; Viorel Vasiliu; Sophie Ferlicot; V Molinié; Y Denoux; N Thiounn; Yves Chrétien; Arnaud Méjean; M Zerbib; Gérard Benoît; jean-marie herve; G Allègre; Brigitte Bressac De-Paillerets; Bin Tean Teh; Stéphane Richard
Mutations in BHD and TP53 genes, but not in HNF1beta gene, in a large series of sporadic chromophobe renal cell carcinoma.
British journal of cancer 2007;96(2):336-40.
2007: Christian Monnerat; Agnès Chompret; Caroline Kannengiesser; Marie-Françoise Avril; Nicolas Janin; Alain Spatz; Jean-Marc Guinebretière; Catalin Marian; Michel Barrois; Françoise Boitier; Gilbert M Lenoir; Brigitte Bressac De-Paillerets
BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma.
Familial cancer 2007;6(4):453-61.
2006: I Templier; Julie Charles; M-C Combe; Brigitte Bressac De-Paillerets; Dominique Leroux; Marie-Thérèse Leccia
[CDKN2A gene mutation and loss of p16 protein activity in a patient on levodopa presenting sporadic multiple primary melanoma].
Annales de dermatologie et de vénéréologie 2006;133(10):777-80.
2006: Gaëlle Bougeard; Stephanie Baert-Desurmont; Isabelle Tournier; S Vasseur; Cosette Martin; L Brugieres; Agnès Chompret; Brigitte Bressac De-Paillerets; Dominique Stoppa-Lyonnet; C Bonaiti-Pellie; Thierry Frebourg
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome.
Journal of medical genetics 2006;43(6):531-3.
2006: Karine Laud; Catalin Marian; Marie-Françoise Avril; Michel Barrois; Agnès Chompret; Alisa M Goldstein; Margaret A Tucker; P A Clark; G Peters; Valérie Chaudru; Florence Demenais; Alain Spatz; M W Smith; Gilbert M Lenoir; Brigitte Bressac De-Paillerets
Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma.
Journal of medical genetics 2006;43(1):39-47.
2005: Laurence Amar; Jérôme Bertherat; Eric Baudin; Christiane Ajzenberg; Brigitte Bressac De-Paillerets; Olivier Chabre; Bernard Chamontin; Brigitte Delemer; Sophie Giraud; Arnaud Murat; Patricia Niccoli-Sire; Stéphane Richard; Vincent Rohmer; Jean-Louis Sadoul; Laurence Strompf; Martin Schlumberger; Xavier Bertagna; Pierre-François Plouin; Xavier Jeunemaitre; Anne-Paule Gimenez-Roqueplo
Genetic testing in pheochromocytoma or functional paraganglioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8812-8.
2005: David J Hughes; Sophie M Ginolhac; Isabelle Coupier; Laure Barjhoux; Valerie Gaborieau; Brigitte Bressac De-Paillerets; Agnès Chompret; Yves-Jean Bignon; Nancy Uhrhammer; Christine Lasset; Sophie Giraud; Hagay Sobol; Agnès Hardouin; Pascaline Berthet; Jean-Philippe Peyrat; Joëlle Fournier; Catherine Nogues; Rosette Lidereau; Danièle Muller; Jean-Pierre Fricker; Michel Longy; Christine Toulas; Rosine Guimbaud; Drakoulis Yannoukakos; Sylvie Mazoyer; Henry T Lynch; Gilbert M Lenoir; David E Goldgar; Dominique Stoppa-Lyonnet; Olga M Sinilnikova
Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene.
International journal of cancer. Journal international du cancer 2005;117(2):230-3.
2005: Valérie Chaudru; Karine Laud; Marie-Françoise Avril; Annie Minière; Agnès Chompret; Brigitte Bressac De-Paillerets; Florence Demenais
Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(10):2384-90.
2005: Catalin Marian; Alon Scope; Karine Laud; Eitan Friedman; Felix Pavlotsky; Emanuel Yakobson; Brigitte Bressac De-Paillerets; Esther Azizi
Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours.
British journal of cancer 2005;92(12):2278-85.
2004: Valérie Chaudru; Agnès Chompret; Brigitte Bressac De-Paillerets; Alain Spatz; Marie-Françoise Avril; Florence Demenais
Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families.
Journal of the National Cancer Institute 2004;96(10):785-95.
2004: Alain Spatz; Brigitte Bressac De-Paillerets; Eric Raymond
Soft tissue sarcomas. Case 3. Gastrointestinal stromal tumor and Carney's triad.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(10):2029-31.
2004: Patricia Pautier; Morice Philippe; Suzette Delaloge; Brigitte Bressac De-Paillerets; Alain Spatz
Is systemic disease in the coelomic epithelium associated with BRCA1 germline mutations?
Journal of the National Cancer Institute 2004;96(6):488-9.
2004: Michel Barrois; Ivan Bièche; Sylvie Mazoyer; MH Champème; Brigitte Bressac De-Paillerets; Rosette Lidereau
Real-time PCR-based gene dosage assay for detecting BRCA1 rearrangements in breast-ovarian cancer families.
Clinical genetics 2004;65(2):131-6.
2004: Agnès Chompret; Caroline Kannengiesser; Michel Barrois; Philippe Terrier; Philippe Dahan; Thomas Tursz; Gilbert M Lenoir; Brigitte Bressac De-Paillerets
PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor.
Gastroenterology 2004;126(1):318-21.
2003: Caroline Kannengiesser; Marie-Françoise Avril; Alain Spatz; Karine Laud; Gilbert M Lenoir; Brigitte Bressac De-Paillerets
CDKN2A as a uveal and cutaneous melanoma susceptibility gene.
Genes, chromosomes & cancer 2003;38(3):265-8.
2003: Elizabeth M Gillanders; Suh-Hang Hank Juo; Elizabeth A Holland; MaryPat Jones; Derek Nancarrow; Diana Freas-Lutz; Raman Sood; Naeun Park; Mezbah U Faruque; Carol Markey; Richard F Kefford; Jane Palmer; Wilma Bergman; D Timothy Bishop; Margaret A Tucker; Brigitte Bressac De-Paillerets; Johan Hansson; Mitchell Stark; Nelleke A Gruis; Julia Newton Bishop; Alisa M Goldstein; Joan E Bailey-Wilson; Graham J Mann; Nicholas Hayward; Jeffrey M. Trent
Localization of a novel melanoma susceptibility locus to 1p22.
American journal of human genetics 2003;73(2):301-13.
2003: Karine Laud; Caroline Kannengiesser; Marie-Françoise Avril; Agnès Chompret; Dominique Stoppa-Lyonnet; Laurence Desjardins; Alain Eychene; Florence Demenais; Gilbert M Lenoir; Brigitte Bressac De-Paillerets
BRAF as a melanoma susceptibility candidate gene?
Cancer research 2003;63(12):3061-5.
2003: Sophie Gad; Ivan Bièche; Michel Barrois; Federica Casilli; Sabine Pages-Berhouet; Catherine Dehainault; Marion Gauthier-Villars; Aaron Bensimon; Alain Aurias; Rosette Lidereau; Brigitte Bressac De-Paillerets; Mario Tosi; Sylvie Mazoyer; Dominique Stoppa-Lyonnet
Characterisation of a 161 kb deletion extending from the NBR1 to the BRCA1 genes in a French breast-ovarian cancer family.
Human mutation 2003;21(6):654.
2003: Emanuel Yakobson; Shlomit Eisenberg; Ruth Isacson; David Halle; Ephrat Levy-Lahad; Raphael Catane; Mark Safro; Vladimir Sobolev; Thomas Huot; Gordon Peters; Anna Ruiz; Josep Malvehy; Suzana Puig; Agnès Chompret; Marie-Fracoise Avril; Raphael Shafir; Hava Peretz; Brigitte Bressac De-Paillerets
A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families.
European journal of human genetics : EJHG 2003;11(4):288-96.
2003: Gaëlle Bougeard; Laurence Brugières; Agnès Chompret; Paul Gesta; Frédéric Charbonnier; Alexander Valent; Cosette Martin; Gregory RAUX; Jean Feunteun; Brigitte Bressac De-Paillerets; Thierry Frébourg
Screening for TP53 rearrangements in families with the Li-Fraumeni syndrome reveals a complete deletion of the TP53 gene.
Oncogene 2003;22(6):840-6.
2003: Christine Sevilla; Claire Julian-Reynier; François Eisinger; Dominique Stoppa-Lyonnet; Brigitte Bressac De-Paillerets; Hagay Sobol; Jean-Paul Moatti
Impact of gene patents on the cost-effective delivery of care: the case of BRCA1 genetic testing.
International journal of technology assessment in health care 2003;19(2):287-300.
2003: David C Y Fung; Elizabeth A Holland; Therese M Becker; Nicholas K Hayward; Brigitte Bressac De-Paillerets; Graham J Mann
eMelanoBase: an online locus-specific variant database for familial melanoma.
Human mutation 2003;21(1):2-7.
2002: Richard F Kefford; Julia Newton Bishop; Margaret Tucker; Brigitte Bressac De-Paillerets; Giovanna Bianchi-Scarrá; Wilma Bergman; Alisa Goldstein; Susana Puig; Rona Mackie; David E Elder; Johan Hansson; Nicholas Hayward; David Hogg; Håkan Olsson
Genetic testing for melanoma.
The lancet oncology 2002;3(11):653-4.
2002: Christine Sevilla; Jean-Paul Moatti; Claire Julian-Reynier; François Eisinger; Dominique Stoppa-Lyonnet; Brigitte Bressac De-Paillerets; Hagay Sobol
Testing for BRCA1 mutations: a cost-effectiveness analysis.
European journal of human genetics : EJHG 2002;10(10):599-606.
2002: D Timothy Bishop; Florence Demenais; Alisa M Goldstein; Wilma Bergman; Julia Newton Bishop; Brigitte Bressac De-Paillerets; Agnès Chompret; Paola Ghiorzo; Nelleke A Gruis; Johan Hansson; Mark Harland; Nicholas Hayward; Elizabeth A Holland; Graham J Mann; Michela Mantelli; Derek Nancarrow; Anton Platz; Margaret A Tucker
Geographical variation in the penetrance of CDKN2A mutations for melanoma.
Journal of the National Cancer Institute 2002;94(12):894-903.
2002: Lucía Delgado; Graciela Fernández; Andrés González; Brigitte Bressac De-Paillerets; Gabriela Gualco; Johny Bombled; Sandra Cataldi; Graciela Sabini; Ricardo Roca; Ignacio M Musé
Hereditary breast cancer associated with a germline BRCA2 mutation in identical female twins with similar disease expression.
Cancer genetics and cytogenetics 2002;133(1):24-8.
2002: Birgit Geoerger; jacques grill; Paule Opolon; Jackie Morizet; Geneviève Aubert; Marie-José Terrier-Lacombe; Brigitte Bressac De-Paillerets; Michel Barrois; Jean Feunteun; David H Kirn; Gilles Vassal
Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts.
Cancer research 2002;62(3):764-72.
2002: Brigitte Bressac De-Paillerets; Marie-Françoise Avril; Agnès Chompret; Florence Demenais
Genetic and environmental factors in cutaneous malignant melanoma.
Biochimie 2002;84(1):67-74.
2001: S Auroy; Marie-Françoise Avril; Agnès Chompret; Danielle Pham; Alisa M Goldstein; Giovanna Bianchi-Scarrà; T Frebourg; P Joly; Alain Spatz; C Rubino; Florence Demenais; Brigitte Bressac De-Paillerets
Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect.
Genes, chromosomes & cancer 2001;32(3):195-202.
2001: Béatrice Geoffroy-Perez; Nicolas Janin; Katia Ossian; Anthony Laugé; M F Croquette; C Griscelli; M Debré; Brigitte Bressac De-Paillerets; A Aurias; Dominique Stoppa-Lyonnet; Nadine Andrieu
Cancer risk in heterozygotes for ataxia-telangiectasia.
International journal of cancer. Journal international du cancer 2001;93(2):288-93.
2001: Thierry Frebourg; Anne Abel; C Bonaiti-Pellie; Laurence Brugières; Pascaline Berthet; Brigitte Bressac De-Paillerets; A Chevrier; Agnès Chompret; O Cohen-Haguenauer; O Delattre; JOSUE FEINGOLD; Jean Feunteun; D Frappaz; J P Fricker; P Gesta; Philippe Jonveaux; Chantal Kalifa; Christine Lasset; Bruno Leheup; Jean-Marc Limacher; Michel Longy; Catherine Nogues; Daniel Oppenheim; Danièle Sommelet; F Soubrier; claude stoll; Dominique Stoppa-Lyonnet; H Tristant
[Li-Fraumeni syndrome: update, new data and guidelines for clinical management].
Bulletin du cancer 2001;88(6):581-7.
2001: Ana Vega; Berta Campos; Brigitte Bressac De-Paillerets; P M Bond; Nicolas Janin; F S Douglas; Montserrat Domènech; Manel Baena; Carles Pericay; Carmen Alonso; Angel Carracedo; Montserrat Baiget; Orland Diez
The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript.
Human mutation 2001;17(6):520-1.
2001: Marie-Françoise Avril; Agnès Chompret; L Verne-Fourment; Marie-José Terrier-Lacombe; Alain Spatz; Karim Fizazi; Brigitte Bressac De-Paillerets; Florence Demenais; Christine Théodore
Association between germ cell tumours, large numbers of naevi, atypical naevi and melanoma.
Melanoma research 2001;11(2):117-22.
2000: Paola Ciotti; Jeffery Struewing; Michela Mantelli; Agnès Chompret; Marie-Françoise Avril; Pier Luigi Santi; Margaret A Tucker; Giovanna Bianchi-Scarrà; Brigitte Bressac De-Paillerets; Alisa M Goldstein
A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families.
American journal of human genetics 2000;67(2):311-9.
2000: Laurent Briollais; Agnès Chompret; Michel Guilloud-Bataille; Brigitte Bressac De-Paillerets; M F Avril; Florence Demenais
Patterns of familial aggregation of three melanoma risk factors: great number of naevi, light phototype and high degree of sun exposure.
International journal of epidemiology 2000;29(3):408-15.
2000: Agnès Chompret; Laurence Brugières; M Ronsin; M Gardes; F Dessarps-Freichey; Anne Abel; D Hua; Laurent Ligot; Marie-Gabrielle Dondon; Brigitte Bressac De-Paillerets; Thierry Frébourg; Jean Lemerle; Catherine Bonaïti-Pellié; Jean Feunteun
P53 germline mutations in childhood cancers and cancer risk for carrier individuals.
British journal of cancer 2000;82(12):1932-7.
2000: Barbara Dieumegard; Sophie Grandjouan; Jean-Christophe Sabourin; ML Le Bihan; I Lefrère; Jean-Pierre Pignon; Philippe Rougier; Philippe Lasser; Jean Bénard; Daniel Couturier; Brigitte Bressac De-Paillerets
Extensive molecular screening for hereditary non-polyposis colorectal cancer.
British journal of cancer 2000;82(4):871-80.
2000: Nadem Soufir; Brigitte Bressac De-Paillerets; Laurence Desjardins; Christine Lévy; Johny Bombled; Isabelle Gorin; Pierre Schlienger; Dominique Stoppa-Lyonnet
Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes.
British journal of cancer 2000;82(4):818-22.
1999: M X Doré; Barbara Dieumegard; Sophie Grandjouan; Marie-Françoise Avril; C Martinet; Michel Ducreux; Philippe Lasser; Brigitte Bressac De-Paillerets
[Muir-Torre syndrome and familial colorectal cancer: 2 families with molecular genetic analysis].
Annales de dermatologie et de vénéréologie 1999;126(8-9):582-6.
1999: Nicolas Janin; Nadine Andrieu; Katia Ossian; Anthony Laugé; M F Croquette; C Griscelli; M Debré; Brigitte Bressac De-Paillerets; A Aurias; Dominique Stoppa-Lyonnet
Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families.
British journal of cancer 1999;80(7):1042-5.
1998: Philippe Jais; Jean-Christophe Sabourin; Johny Bombled; Philippe Rougier; Philippe Lasser; Pierre Duvillard; Jean Bénard; Brigitte Bressac De-Paillerets
Absence of somatic alterations of the EB1 gene adenomatous polyposis coli-associated protein in human sporadic colorectal cancers.
British journal of cancer 1998;78(10):1356-60.
1998: Marie-Agnès Dragon-Durey; AF Goguel; C Leonard; R Berger; Brigitte Bressac De-Paillerets; Didier Fauvet; Alain BERNHEIM
Non-Hodgkin's lymphomas and myeloid disorders: deletions associated with t(2;5) and t(3;5) detected by FISH.
Leukemia 1998;12(7):1159-62.
1998: François Eisinger; Jocelyne Jacquemier; C Charpin; D Stoppa-Lyonnet; Brigitte Bressac De-Paillerets; Jean-Philippe Peyrat; Michel Longy; Jean-Marc Guinebretière; Richard Sauvan; Tetsuro Noguchi; Daniel Birnbaum; Hagay Sobol
Mutations at BRCA1: the medullary breast carcinoma revisited.
Cancer research 1998;58(8):1588-92.
1998: C Capoulade; Brigitte Bressac De-Paillerets; I Lefrère; M Ronsin; Jean Feunteun; Thomas Tursz; Joëlle Wiels
Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells.
Oncogene 1998;16(12):1603-10.
1998: Nadem Soufir; Marie-Françoise Avril; Agnès Chompret; Florence Demenais; Johny Bombled; Alain Spatz; Dominique Stoppa-Lyonnet; Jean Bénard; Brigitte Bressac De-Paillerets
Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.
Human molecular genetics 1998;7(2):209-16.
1998: Jean Bénard; Brigitte Bressac De-Paillerets
[Update on genetic markers of cancer].
Bulletin du cancer 1998;85(1):21-6.
1997: OM Serova-Sinilnikova; L Boutrand; Dominique Stoppa-Lyonnet; Brigitte Bressac De-Paillerets; V Dubois; Christine Lasset; Nicolas Janin; Yves-Jean Bignon; Michel Longy; Christine Maugard; Rosette Lidereau; Dominique Leroux; Thierry Frebourg; Sylvie Mazoyer; Gilbert M Lenoir
BRCA2 mutations in hereditary breast and ovarian cancer in France.
American journal of human genetics 1997;60(5):1236-9.
1996: Gilles Vassal; Marie-José Terrier-Lacombe; MC Bissery; Anne-Marie Vénuat; F Gyergyay; Jean Bénard; Jackie Morizet; I Boland; Patrice Ardouin; Brigitte Bressac De-Paillerets; Alain Gouyette
Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts.
British journal of cancer 1996;74(4):537-45.
1996: H Sobol; D Stoppa-Lyonnet; Brigitte Bressac De-Paillerets; Jean-Philippe Peyrat; F Kerangueven; Nicolas Janin; T Noguchi; F Eisinger; J M Guinebretiere; Jocelyne Jacquemier; Daniel Birnbaum
Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers.
Cancer research 1996;56(14):3216-9.
1994: Vladimir Lazar; Sophie Grandjouan; C Bognel; D Couturier; Philippe Rougier; Dominique Bellet; Brigitte Bressac De-Paillerets
Accumulation of multiple mutations in tumour suppressor genes during colorectal tumorigenesis in HNPCC patients.
Human molecular genetics 1994;3(12):2257-60.